person · Reporting owner

Hinrichs James F.

Disclosed activity across 5 companies

Tapewire entity: 44858
SEC CIK: 0001506974

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Acutus Medical, Inc.AFIB · Entity 83848	Director	June 16, 2022	June 21, 2022
Integer Holdings CorpITGR · Entity 4016	Director	May 20, 2026	May 22, 2026
Orthofix Medical Inc.OFIX · Entity 1975	Director	September 14, 2023	September 14, 2023
Outset Medical, Inc.OM · Entity 7026	Director	May 29, 2024	May 29, 2024

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Acutus Medical, Inc.

Report date June 16, 2022 · Filed June 21, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	61,311	Reported balance After 2022-06-16 transaction · row 1 1 source row Row 1 · 2022-06-16 · Grant · Acquired 8,400 · Balance 61,311 F1: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2032-06-16	Direct	19,600	Reported balance After 2022-06-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2022-06-16 · Grant · Acquired 19,600 · Balance 19,600 F2: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director.
Common StockSEC Table I · non-derivative	IndirectBy Hinrichs Joint Revocable Trust	14,999	Reported balance Holding disclosure · report date 2022-06-16 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 14,999

Filing footnotes · ownership attribution and instrument terms

F1: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director.

F2: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director.

Integer Holdings Corp

Report date May 20, 2026 · Filed May 22, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	1,967	Reported balance After 2026-05-20 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-05-20 · Grant · Acquired 1,967 · Balance 1,967 F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.

F2: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer.

Orthofix Medical Inc.

Report date September 14, 2023 · Filed September 14, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	86,153	Reported balance After 2023-09-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2023-09-14 · Purchase · Acquired 7,500 · Balance 86,153 F1: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2: Includes 39,548 deferred stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.

F2: Includes 39,548 deferred stock units.

Outset Medical, Inc.

Report date May 29, 2024 · Filed May 29, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	80,349	Reported balance After 2024-05-29 transaction · row 1 1 source row Row 1 · 2024-05-29 · Grant · Acquired 25,000 · Balance 80,349 F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Filing footnotes · ownership attribution and instrument terms

F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ALERE INC.

Report date October 03, 2017 · Filed October 03, 2017

Section 16 reporting ended · disclosed 2017-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2017-10-03 transaction · row 1 1 source row Row 1 · 2017-10-03 · Disposition to issuer · Disposed 72,230 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.48	Direct	Reported balance After 2017-10-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2017-10-03 · Disposition to issuer · Disposed 108,118 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.08	Direct	Reported balance After 2017-10-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-10-03 · Disposition to issuer · Disposed 250,000 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2017-10-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2017-10-03 · Disposition to issuer · Disposed 44,350 · Balance 0 F3: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").

F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.

F3: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 03, 2017 Filed Oct 3, 2017 17:35 UTC	ALERE INC. ALR · Entity 172772	Disposition to issuerRestricted Stock Units · Derivative	44,350	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-001787 · es1701011_4-hinrichs.xml · derivative · entry 4 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 44,350 shares Expires not disclosed F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F3 · price: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. Read SEC document
October 03, 2017 Filed Oct 3, 2017 17:35 UTC	ALERE INC. ALR · Entity 172772	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	250,000	Not disclosed Strike: $50.08	Not disclosed	Disclosure SEC source: 0000950142-17-001787 · es1701011_4-hinrichs.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250,000 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. Read SEC document
October 03, 2017 Filed Oct 3, 2017 17:35 UTC	ALERE INC. ALR · Entity 172772	Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative	108,118	Not disclosed Strike: $47.48	Not disclosed	Disclosure SEC source: 0000950142-17-001787 · es1701011_4-hinrichs.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,118 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. Read SEC document
October 03, 2017 Filed Oct 3, 2017 17:35 UTC	ALERE INC. ALR · Entity 172772	Disposition to issuerCommon Stock	72,230	Not disclosed	Not disclosed	Disclosure SEC source: 0000950142-17-001787 · es1701011_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration"). Read SEC document
July 03, 2017 Filed Jul 10, 2017 21:54 UTC	Orthofix Medical Inc. OFIX · Entity 1975	GrantCommon Stock	3,579	$0.00	$0.00	Disclosure SEC source: 0001209191-17-044649 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,638 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 3, 2018. Vested shares of common stock will be delivered to the reporting person within 45 days after termination of service as a director. Read SEC document
April 06, 2017 Filed Apr 10, 2017 18:18 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionRestricted Stock Units · Derivative	16,667	$0.00	$0.00	Disclosure SEC source: 0001179110-17-005909 · edgar.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 16,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. F2 · derivative.exercise_date: On April 10, 2015, the reporting person was granted 50,000 restricted stock units which vest as follows: 16,666 on the first anniversary of the grant date (4/06/16); 16,667 on the second anniversary of the grant date (4/06/17); and 16,667 on the third anniversary of the grant date (4/06/18). F2 · derivative.expiration_date: On April 10, 2015, the reporting person was granted 50,000 restricted stock units which vest as follows: 16,666 on the first anniversary of the grant date (4/06/16); 16,667 on the second anniversary of the grant date (4/06/17); and 16,667 on the third anniversary of the grant date (4/06/18). Read SEC document
April 06, 2017 Filed Apr 10, 2017 18:18 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionCommon Stock	16,667	Not disclosed	Not disclosed	Disclosure SEC source: 0001179110-17-005909 · edgar.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. Read SEC document
February 16, 2017 Filed Feb 21, 2017 18:18 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionRestricted Stock Units · Derivative	13,842	$0.00	$0.00	Disclosure SEC source: 0001179110-17-002827 · edgar.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,683 Underlying: Common Stock · 13,842 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. F2 · derivative.exercise_date: On February 16, 2016 the reporting person was granted 41,525 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19). F2 · derivative.expiration_date: On February 16, 2016 the reporting person was granted 41,525 restricted stock units which vest as follows: one-third on the first anniversary of the grant date (2/16/17); one-third on the second anniversary of the grant date (2/16/18); and one-third on the third anniversary of the grant date (2/16/19). Read SEC document
February 16, 2017 Filed Feb 21, 2017 18:18 UTC	ALERE INC. ALR · Entity 172772	Tax withholdingCommon Stock	5,260	$40.40	$212,504.00	Disclosure SEC source: 0001179110-17-002827 · edgar.xml · nonDerivative · entry 2 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,563 Read SEC document
February 16, 2017 Filed Feb 21, 2017 18:18 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionCommon Stock	13,842	Not disclosed	Not disclosed	Disclosure SEC source: 0001179110-17-002827 · edgar.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,823 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. Read SEC document
November 30, 2016 Filed Feb 15, 2017 18:01 UTC	ALERE INC. ALR · Entity 172772	OtherCommon Stock	315	$33.73	$10,624.32	Disclosure SEC source: 0001179110-17-002461 · edgar.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,981 F1 · kind: These securities were acquired under the Alere Inc. Employee Stock Purchase Plan. This transaction, which is exempt from Section 16(b) by virtue of Rule 16b-3(c), is being voluntarily reported. Read SEC document
September 09, 2016 Filed Sep 13, 2016 17:25 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionRestricted Stock Units · Derivative	16,666	$0.00	$0.00	Disclosure SEC source: 0001179110-16-029622 · edgar.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 16,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. F2 · derivative.exercise_date: The restricted units were awarded pursuant to a restricted stock unit on April 10, 2015, and will vest as follows: 16,666 on the first anniversary of the grant date (4/06/16); 16,667 on the second anniversary of the grant date (4/06/17); and 16,667 on the third anniversary of the grant date (4/06/18). F2 · derivative.expiration_date: The restricted units were awarded pursuant to a restricted stock unit on April 10, 2015, and will vest as follows: 16,666 on the first anniversary of the grant date (4/06/16); 16,667 on the second anniversary of the grant date (4/06/17); and 16,667 on the third anniversary of the grant date (4/06/18). Read SEC document
September 09, 2016 Filed Sep 13, 2016 17:25 UTC	ALERE INC. ALR · Entity 172772	Exercise / conversionCommon Stock	16,666	Not disclosed	Not disclosed	Disclosure SEC source: 0001179110-16-029622 · edgar.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Executive VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,666 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · date: Vesting of shares under the Alere 2010 Stock Option and Incentive Plan was suspended from March 1, 2016 until two business days after Alere's SEC filings became current. Shares vested on September 9, 2016 represent shares that otherwise would have vested during the suspension period. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.